Channe Sales Executive
Opella is a global leader in the OTC and VMS market seeking a Channel Sales Executive based in Chennai to drive revenue through indirect sales networks. The role focuses on partner relationship management, sales strategy execution, and sales performance analysis to ensure market growth. Candidates need proficiency in CRM tools and a strong background in channel sales and business development. This position offers the opportunity to work with globally recognized healthcare and self-care brands.
50k new jobs listed every day. Install TAL to find more jobs like this.
Experience
Experience not specified
Function
Sales
Work mode
Onsite, India
Company
Tier 2
What you will work on
Opella is a global leader in the OTC and VMS market seeking a Channel Sales Executive based in Chennai to drive revenue through indirect sales networks. The role focuses on partner relationship management, sales strategy execution, and sales performance analysis to ensure market growth. Candidates need proficiency in CRM tools and a strong background in channel sales and business development. This position offers the opportunity to work with globally recognized healthcare and self-care brands.
TAL's take
Solid multinational consumer health company offering a clear functional role with defined responsibilities.
The JD clearly defines the channel sales management responsibilities, metrics, and partnership expectations.
Salaries at Opella
36.0 LPA average
Based on 1 Grapevine salary entries for Opella.
Other roles
10 - 12 years | CL3
36 LPA average
Range: 36 - 36 LPA
Must haves
- Strong sales and business development skills
- Excellent communication and interpersonal skills
- Proven ability to build and manage relationships with partners
- Understanding of channel sales strategies and best practices
- Ability to analyze sales data
- Proficiency in using CRM and other sales tools
- Strong negotiation and influencing skills
Tools and skills
About the company
Established global consumer health company, but not a tech-native Tier 1 firm.
Posts mentioning Opella
How is Opella Health care for joining as SAP cobsultant with 8 + Experince.
Please suggest is Opella Healthcare is good for SAP consultants,i did google getting 50 50 review for pros and cons..
Recent Resignations
Notable executive departures disclosed in the past week include: Both Co-CEOs of Sprinklr (NYSE: CXM — $1.92 billion) “mutually agreed” to depart after five months and fifteen years, respectively; they were replaced by an outside candidate who was previously CEO of Vonage. In February, the company’s Chief Revenue Officer “stepped down” after a little over one year. The company is down ~65% since its June 2021 IPO. CFO of Openlane (NYSE: KAR — $2.11 billion), formerly KAR Auction Services, “will resign from the company effective March 1, 2025 to pursue another opportunity closer to family” after two years. CEO of Sun Communities (NYSE: SUI — $15.6 billion) “has informed the board of his intention to retire in 2025” after 32 years and the board has “established a CEO Succession Planning Committee.” In September 2024, Blue Orca Capital called the company “a mess of egregious executive behavior” and found that Sun’s CEO “received an undisclosed $4 million loan from the family of a supposedly independent Director who sits on the Audit Committee” and also separately “admitted borrowing $700K from a director whose law firm also serves as [Sun’s] general counsel.” Chief Operating Officer of DXC Technology (NYSE: DXC — $3.92 billion) “will be exiting the company” after nearly two years. The company’s General Counsel also departed in March and the company’s former CEO stepped down in December 2023. Chief Commercial Officer of QuidelOrtho Corp (NASDAQ: QDEL — $2.94 billion) was “terminated” after two and a half years along with the company’s Chief Operating Officer who was “terminated” after four years. In February, the company’s CEO was also “terminated” after fifteen years. Chief Accounting Officer of Hippo Holdings (NYSE: HIPO — $701 million) “entered into a separation agreement” after a little over three years. In October, the company’s Chief Revenue Officer also departed after four years. In March 2023, the company replaced Ernst & Young as its a